Treatments like sotrovimab, molnupiravir and Paxlovid could lead to a new strategy in 2022: tackling covid-19 soon after infection to prevent severe symptoms from developing
Treatments like sotrovimab, molnupiravir and Paxlovid could lead to a new strategy in 2022: tackling covid-19 soon after infection to prevent severe symptoms from developing